00002-7669
                        
                    
                            Cyramza
                        
                    
                                    Ramucirumab
                                
                            
                        
                    
                            Solution
                        
                    
                                    Intravenous
                                
                            
                        
                    
                                     Ramucirumab
                                
                                
                                     10.0
                                
                                
                                     mg/mL
                                
                                
                            
                        
                    
                                     00002-7669-01
                                
                                
                                     1 VIAL, SINGLE-DOSE in 1 CARTON (0002-7669-01)  / 10 mL in 1 VIAL, SINGLE-DOSE
                                
                                
                                     April 21, 2014
                                
                                
                                    Immunotherapy
                                
                            
                        
                    
                                    Monoclonal Antibody
                                
                            
                        
                    
                                    VEGF
                                
                            
                        
                    
                            In Use
                        
                     An official website of the United States government
 An official website of the United States government
		 Home
 Home 
                             
                    